Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies
from The Wistar Institute via ScienceDaily
Scientists have successfully engineered novel DNA-encoded monoclonal antibodies targeting Zaire Ebolavirus that were effective in preclinical models. Study results showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063